期刊文献+

脂质体对7-乙基-10-羟基喜树碱稳定性影响 被引量:5

Effect of liposomes on stability of 7-ethyl-10-hydroxycamptothecin
原文传递
导出
摘要 目的考察脂质体对7-乙基-10-羟基喜树碱(7-ethyl-10-hydroxycamptothecin,SN-38)活性形式的保护作用。方法建立测定SN-38活性形式的HPLC法,考察不同pH条件对SN-38活性与SN-38非活性形式相互转变动力学和平衡比例的影响;并研究了37℃的pH 7.4、8.0、9.0、10.0条件下脂质体对SN-38活性形式的保护作用。结果在pH<4.3的条件下,SN-38以其活性形式存在;在pH>9的条件下,SN-38主要以其非活性形式存在;在pH 6.5的条件下,SN-38活性和非活性形式之间相互转换最慢。包裹在脂质体内的SN-38在模拟生理条件下8 h活性形式质量分数仍大于98%。结论脂质体能够有效地保护SN-38α-羟基内酯环。 Objective To study the protection effect of liposome on lactone ring of 7-ethyl-10-hydroxycamptothecin(SN-38).Methods The interconversion kinetics and equilibrium ratio of SN-38 active and inactive forms(SN-38I)under different pH conditions were investigated with an HPLC method,which was developed for simultaneous quantification of SN-38 active and inactive forms in the liposomes.The concentration and equilibrium ratio of active form were measured under different pH including pH 7.4,pH 8.0,pH 9.0,pH 10.0 at 37 ℃.Results SN-38 was existed in the active form at pH of less than 4.3 and mainly in the inactive form at pH of greater than 9.0.The rate of interconversion between active and inactive form was minimum at pH 6.5.Moreover,the active form ratio of encapsulated SN-38 in liposomes was more than 98% under simulated physiological condition in 8 hours.Conclusions The α-hydroxy lactone ring of SN-38 can be effectively stabilized by liposome.
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2012年第7期491-496,共6页 Journal of Shenyang Pharmaceutical University
关键词 7-乙基-10-羟基喜树碱 脂质体 平衡 动力学 高效液相色谱法 7-ethyl-10-hydroxycamptothecin liposome equlibrium kinetics HPLC
  • 相关文献

参考文献13

  • 1JONES J M. Physician desk reference:57th ed[M]. Montvale, 2003: 218.
  • 2TAKIMOTO C H, ARUCK S G. Cancer chemotherapy and biotherapy: principles and practice:3rd ed[M]. Philadelphia: Lippincott Williams & Wilkins, 2001: 579-646.
  • 3HSIANG Y H, LIHOU M G, LIU L F. Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin[J]. Cancer Res, 1989, 49: 5077-5082.
  • 4WANI M C, NICHOLAS A W, MANIKUMAR G, et al. Plant antitumor agents. 25. Total synthesis and antileukemic activity of ring A substituted camptothecin analogs. Structure-activity correlations[J]. J Med Chem, 1987, 30(10): 1774-1779.
  • 5BURKE T G, MI Z. Ethyl substitution at the 7 position extends the half-life of 10-hydroxycamptothecin in the presence of human serum albumin[J]. Med Chem, 1993, 36: 2580-2582.
  • 6BURKE T G, STAUBUS A E, MISHRA A K. Liposomal stabilization of camptothecin’s lactone ring[J]. Am Chem Soc, 1992, 114: 8318-8319.
  • 7MI Z, BURKE T G. Marked interspecies variations concerning the interactions of camptothecin with serum albumins: a frequency-domain &#64258;uorescence spectroscopic study[J]. Biochemistry, 1994, 33: 12540-12545.
  • 8SHENDEROVA A,BURKE T G,SCHWENDEMAN S P.Stabilization of 10-hydroxycamptothecin in poly (lactide-co-glycolide) microsphere delivery vehicles[J]. Pharmaceutical research, 1997, 14(10): 1406-1414.
  • 9TONG Xuan, ZHANG A J, AHMAD I. HPLC method for determination of SN-38 content and SN-38 entrapment ef&#64257;ciency in a novel liposome-based formulation, LE-SN38[J]. Journal of pharmaceutical and biomedical analysis, 2006, 41: 582-588.
  • 10周卫,丁逸梅,王丽杰.脂质体对羟喜树碱内酯环的保护[J].中国药学杂志,2005,40(9):688-690. 被引量:7

二级参考文献8

共引文献11

同被引文献40

引证文献5

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部